|
|
Volumn 23, Issue 3, 2006, Pages 445-446
|
|
Thalidomide: An effective anabolic agent in gastrointestinal cancer cachexia [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANABOLIC AGENT;
CYTOKINE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MEGESTROL;
PENTOXIFYLLINE;
PLACEBO;
THALIDOMIDE;
TRANSCRIPTION FACTOR;
ANOREXIA;
APOPTOSIS;
APPETITE;
BODY MASS;
CACHEXIA;
CANCER STAGING;
CELL DIFFERENTIATION;
CELL GROWTH;
CLINICAL FEATURE;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
DIETARY INTAKE;
DIGESTIVE SYSTEM CANCER;
DOWN REGULATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
ESOPHAGUS CARCINOMA;
GASTROINTESTINAL CARCINOMA;
GENE EXPRESSION REGULATION;
HUMAN;
INSOMNIA;
LEAN BODY WEIGHT;
LETTER;
LIFE EXPECTANCY;
NAUSEA;
NUTRITIONAL SUPPORT;
PANCREAS CARCINOMA;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REGULATORY MECHANISM;
SUPPLEMENTATION;
TREATMENT PLANNING;
WEIGHT GAIN;
WEIGHT REDUCTION;
ANABOLIC AGENTS;
CACHEXIA;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
THALIDOMIDE;
|
|
EID: 33644900463
PISSN: 02692813
EISSN: 13652036
Source Type: Journal
DOI: 10.1111/j.1365-2036.2006.02738.x Document Type: Letter |
|
Times cited : (5)
|
|
References (6)
|
